Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Field

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|February 24, 2006
cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilator-stimulated phosphoprotein associationBenjamin H Fryer, Changhui Wang, Srilakshmi Vedantam, et al.
JCI Insight|February 15, 2019
Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onsetYao Xiong, Kenneth Bedi, Simon Berritt, et al.
The Annals of Thoracic Surgery|May 28, 2005
Bacterial pericarditis due to group F streptococci as a complication of esophagomediastinal fistulaRajesh Kabra, Karl F Welke, Kemp H Kernstine, et al.
Chemical Research in Toxicology|May 21, 2008
The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominanceJong-Heum Park, Stacy Gelhaus, Srilakshmi Vedantam, et al.
The American Journal of Chinese Medicine|July 18, 2022
Tangeretin Synergizes with 5-Fluorouracil to Induce Autophagy through MicroRNA-21 in Colorectal Cancer CellsYang Bai, Yao Xiong, Yuan-Yuan Zhang, et al.
The Journal of Biological Chemistry|August 21, 2013
FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated SchwannomasSilvia Licciulli, Jasna Maksimoska, Chun Zhou, et al.
American Journal of Medical Genetics. Part A|December 4, 2021
A homozygous CAP2 pathogenic variant in a neonate presenting with rapidly progressive cardiomyopathy and nemaline rodsSharavana Gurunathan, Jessica Sebastian, Jennifer Baker, et al.
American Journal of Cancer Research|April 9, 2020
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomasJianman Guo, Katherine E Chaney, Kwangmin Choi, et al.
Scientific Reports|June 1, 2016
Erratum: CAP2 in cardiac conduction, sudden cardiac death and eye developmentJeffrey Field, Diana Z Ye, Manasi Shinde, et al.
Scientific Reports|December 1, 2015
CAP2 in cardiac conduction, sudden cardiac death and eye developmentJeffrey Field, Diana Z Ye, Manasi Shinde, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|February 24, 2006
cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilator-stimulated phosphoprotein associationBenjamin H Fryer, Changhui Wang, Srilakshmi Vedantam, et al.
JCI Insight|February 15, 2019
Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onsetYao Xiong, Kenneth Bedi, Simon Berritt, et al.
The Annals of Thoracic Surgery|May 28, 2005
Bacterial pericarditis due to group F streptococci as a complication of esophagomediastinal fistulaRajesh Kabra, Karl F Welke, Kemp H Kernstine, et al.
Chemical Research in Toxicology|May 21, 2008
The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominanceJong-Heum Park, Stacy Gelhaus, Srilakshmi Vedantam, et al.
The American Journal of Chinese Medicine|July 18, 2022
Tangeretin Synergizes with 5-Fluorouracil to Induce Autophagy through MicroRNA-21 in Colorectal Cancer CellsYang Bai, Yao Xiong, Yuan-Yuan Zhang, et al.
The Journal of Biological Chemistry|August 21, 2013
FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated SchwannomasSilvia Licciulli, Jasna Maksimoska, Chun Zhou, et al.
American Journal of Medical Genetics. Part A|December 4, 2021
A homozygous CAP2 pathogenic variant in a neonate presenting with rapidly progressive cardiomyopathy and nemaline rodsSharavana Gurunathan, Jessica Sebastian, Jennifer Baker, et al.
American Journal of Cancer Research|April 9, 2020
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomasJianman Guo, Katherine E Chaney, Kwangmin Choi, et al.
Scientific Reports|June 1, 2016
Erratum: CAP2 in cardiac conduction, sudden cardiac death and eye developmentJeffrey Field, Diana Z Ye, Manasi Shinde, et al.
Scientific Reports|December 1, 2015
CAP2 in cardiac conduction, sudden cardiac death and eye developmentJeffrey Field, Diana Z Ye, Manasi Shinde, et al.
Pageof 6